Advertisement
Screener

RECURSION PHARMACEUTICALS, INC. (RXRX) Other

RECURSION PHARMACEUTICALS, INC. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-05-06: Form 10-Q; Item Shares outstanding CommonClassA as of 2026-05-01; As filed 524,677,865.
  • 2026-05-06: Form 10-Q; Item Shares outstanding CommonClassB as of 2026-05-01; As filed 5,227,334.
  • 2026-02-25: Form 10-K; Item Shares outstanding CommonClassA as of 2026-01-31; As filed 521,950,663.
  • 2026-02-25: Form 10-K; Item Shares outstanding CommonClassB as of 2026-01-31; As filed 5,447,334.
FiledFormItemAs filed
2026-05-0610-QShares outstanding CommonClassA as of 2026-05-01524,677,865
2026-05-0610-QShares outstanding CommonClassB as of 2026-05-015,227,334
2026-02-2510-KShares outstanding CommonClassA as of 2026-01-31521,950,663
2026-02-2510-KShares outstanding CommonClassB as of 2026-01-315,447,334
2025-11-0510-QShares outstanding CommonClassA as of 2025-10-31514,895,802
2025-11-0510-QShares outstanding CommonClassB as of 2025-10-315,747,334
2025-08-0510-QShares outstanding CommonClassA as of 2025-07-30427,312,960
2025-08-0510-QShares outstanding CommonClassB as of 2025-07-306,838,575
2025-05-0510-QShares outstanding CommonClassA as of 2025-04-30399,656,573
2025-05-0510-QShares outstanding CommonClassB as of 2025-04-306,838,575
2025-02-2810-KShares outstanding CommonClassA as of 2025-01-31395,072,094
2025-02-2810-KShares outstanding CommonClassB as of 2025-01-316,918,575
2024-11-0610-QShares outstanding CommonClassA as of 2024-10-31279,602,258
2024-11-0610-QShares outstanding CommonClassB as of 2024-10-317,038,575
2024-08-0810-QShares outstanding CommonClassA as of 2024-07-31273,940,019
2024-08-0810-QShares outstanding CommonClassB as of 2024-07-317,168,575
2024-05-0910-QShares outstanding CommonClassA as of 2024-04-30230,273,797
2024-05-0910-QShares outstanding CommonClassB as of 2024-04-307,389,871
2024-02-2910-KShares outstanding CommonClassA as of 2024-01-31227,143,401
2024-02-2910-KShares outstanding CommonClassB as of 2024-01-317,509,871
2023-11-0910-QShares outstanding CommonClassA as of 2023-10-31208,283,925
2023-11-0910-QShares outstanding CommonClassB as of 2023-10-317,589,871
2023-11-0910-QShares outstanding ExchangeableStock as of 2023-10-31749,445
2023-08-0810-QShares outstanding CommonClassA as of 2023-07-31204,038,332
2023-08-0810-QShares outstanding CommonClassB as of 2023-07-317,644,871
2023-08-0810-QShares outstanding ExchangeableStock as of 2023-07-313,905,069
2023-05-0810-QShares outstanding CommonClassA as of 2023-04-30184,643,171
2023-05-0810-QShares outstanding CommonClassB as of 2023-04-307,716,209
2023-02-2710-KShares outstanding CommonClassA as of 2023-01-31183,443,480
2023-02-2710-KShares outstanding CommonClassB as of 2023-01-317,789,209
2022-11-0810-QShares outstanding CommonClassA as of 2022-10-31181,694,536
2022-11-0810-QShares outstanding CommonClassB as of 2022-10-317,861,209
2022-11-0810-QEmerging growth companyYes
2022-08-0910-QShares outstanding CommonClassA as of 2022-07-31165,143,482
2022-08-0910-QShares outstanding CommonClassB as of 2022-07-317,933,209
2022-08-0910-QEmerging growth companyYes
2022-05-1010-QShares outstanding CommonClassA as of 2022-04-30163,834,157
2022-05-1010-QShares outstanding CommonClassB as of 2022-04-308,173,209
2022-05-1010-QEmerging growth companyYes
2022-03-2310-KShares outstanding CommonClassA as of 2022-02-28161,768,235
2022-03-2310-KShares outstanding CommonClassB as of 2022-02-289,005,359
2022-03-2310-KEmerging growth companyYes
2022-03-2310-KWell-known seasoned issuerNo
2021-11-1010-QShares outstanding CommonClassA as of 2021-10-31159,525,190
2021-11-1010-QShares outstanding CommonClassB as of 2021-10-319,467,883
2021-11-1010-QEmerging growth companyYes
2021-08-1310-QShares outstanding CommonClassA as of 2021-07-31159,015,551
2021-08-1310-QShares outstanding CommonClassB as of 2021-07-319,467,883
2021-08-1310-QEmerging growth companyYes
2021-05-1210-QEmerging growth companyYes
2021-05-1210-QCurrent in its reportingNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Vericel Corp (VCEL)United States$2.011B93.97
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Greenland Mines Ltd (GRML)United States$2.362B
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51